Anzeige
Mehr »
Login
Sonntag, 26.09.2021 Börsentäglich über 12.000 News von 673 internationalen Medien
LUKRATIVE NEUVORSTELLUNG IM MEGA-WACHSTUMSMARKT
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CRFU ISIN: US76090R1014 Ticker-Symbol: 24O 
Tradegate
24.09.21
16:17 Uhr
2,430 Euro
-0,060
-2,41 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
RESHAPE LIFESCIENCES INC Chart 1 Jahr
5-Tage-Chart
RESHAPE LIFESCIENCES INC 5-Tage-Chart
RealtimeGeldBriefZeit
2,4602,48025.09.
2,4202,48524.09.

Aktuelle News zur RESHAPE LIFESCIENCES Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
RESHAPE LIFESCIENCES Aktie jetzt für 0€ handeln
DoReShape Lifesciences Inc: ReShape Lifesciences Featured in BioTuesdays-
09.09.ReShape Lifesciences Inc: ReShape Lifesciences to Present at Oppenheimer Fall Healthcare Life Sciences and Med Tech Summit on September 20, 20212
31.08.ReShape Lifesciences Inc: ReShape Lifesciences Appoints Al Diaz as Vice President of Operations and Research and Development2
19.08.RSLS, LQDA and MDIA pre market gainers.3
16.08.ReShape Lifesciences Inc.: ReShape Reports Second Quarter 2021 Financial Results and Provides Business Update433Webinar to follow at 8:30 a.m. ET todaySAN CLEMENTE, CA / ACCESSWIRE / August 16, 2021 / ReShape Lifesciences Inc. (NASDAQ:RSLS), a leading developer and distributor of minimally invasive medical devices...
► Artikel lesen
05.08.ReShape Lifesciences Inc.: ReShape Lifesciences Reports Preliminary Unaudited Second Quarter 2021 Financial Results and Provides Business Update311SAN CLEMENTE, CA / ACCESSWIRE / August 5, 2021 / ReShape Lifesciences Inc. (NASDAQ:RSLS), a leading developer and distributor of minimally invasive medical devices to treat obesity and metabolic diseases...
► Artikel lesen
03.08.ReShape Lifesciences Inc.: ReShape Lifesciences CEO Bart Bandy Featured on the Big Biz Show266SAN CLEMENTE, CA / ACCESSWIRE / August 3, 2021 / ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss solutions company, today announced CEO Bart Bandy's featured interview...
► Artikel lesen
29.07.ReShape Lifesciences Inc.: ReShape Lifesciences to Report Second Quarter 2021 Financial and Operational Results on Thursday, August 5, 2021246Webinar will be available discussing recent major milestones that same daySAN CLEMENTE, CA / ACCESSWIRE / July 29, 2021 / ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss...
► Artikel lesen
19.07.ReShape Lifesciences Inc. - 8-K, Current Report8
13.07.ReShape Lifesciences Inc.: ReShape Lifesciences Launches Online Consumer Marketplace Offering Products Supporting Four Key Dimensions of Wellness: Nutrition, Exercise, Sleep and Stress314SAN CLEMENTE, CA / ACCESSWIRE / July 13, 2021 / ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced the launch of ReShape...
► Artikel lesen
09.07.Galectin Therapeutics, ReShape Lifesciences leads healthcare gainers; Sigilon Therapeutics, Aerpio Pharmaceuticals among major losers11
07.07.ReShape Lifesciences Inc.: ReShape Lifesciences Moves Lap-Band Manufacturing to United States460SAN CLEMENTE, CA / ACCESSWIRE / July 7, 2021 / ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced it has completed...
► Artikel lesen
01.07.ReShape Lifesciences Inc.: ReShape Lifesciences Sees Lap-Band Growth as COVID-19 Pandemic Heightens Obesity Crisis372SAN CLEMENTE, CA / ACCESSWIRE / July 1, 2021 / ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight-loss solutions company, today announced that Lap-Band® utilization has increased...
► Artikel lesen
30.06.ReShape Lifesciences under pressure on completion of a $46M capital raise3
30.06.ReShape Lifesciences Inc.: ReShape Lifesciences Completes $46 Million Capital Raise With Key Institutional Shareholders392Funding provides for the acceleration of its internal growth strategy and the continued development of Reshape's weight-loss portfolioSAN CLEMENTE, CA / ACCESSWIRE / June 30, 2021 / ReShape Lifesciences...
► Artikel lesen
29.06.ReShape Lifesciences Inc.: ReShape Lifesciences Enters into Warrant Exercise Transaction for $46.2 Million in Gross Proceeds467SAN CLEMENTE, CA / ACCESSWIRE / June 29, 2021 / ReShape Lifesciences Inc. (NASDAQ:RSLS), a global weight-loss solutions leader, announced today that it has entered into a warrant exercise agreement...
► Artikel lesen
17.06.ReShape Lifesciences Inc.: ReShape Lifesciences Closes First Day of Trading on the NASDAQ Capital Market473Shares of ReShape Lifesciences commenced trading on The Nasdaq Capital Market at market open on June 16, 2021 under the ticker symbol "RSLS"SAN CLEMENTE, CA / ACCESSWIRE / June 17, 2021 / ReShape Lifesciences...
► Artikel lesen
17.06.XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 17.06.2021845The following instruments on XETRA do have their first trading 17.06.2021 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag am 17.06.2021 Aktien 1 PLDTLGM00019 Detalion Games S.A. 2...
► Artikel lesen
16.06.XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 16.06.2021757The following instruments on Boerse Frankfurt do have their last trading day on 16.06.2021Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 16.06.2021ISIN NameCA30219B1094 EXPERION...
► Artikel lesen
16.06.XFRA ISIN CHANGE457Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: Anmerkungen CBF-Nr.CA30219B1094 Citizen Stash Cannabis Corp. 16.06.2021 CA17291F1080 Citizen Stash Cannabis Corp. 17.06.2021...
► Artikel lesen
Seite:  Weiter >>
45 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
64,1,4